Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer
Open Access
- 20 January 2005
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 48 (2) , 242-250
Abstract
Mutations in hepatic nuclear factor 1α cause a monogenic form of diabetes, maturity onset diabetes of the young type 3 (MODY3). Our aim was (1) to assess the uptake of genetic testing for MODY3 and to determine factors affecting it, and (2) to compare attitudes to predictive genetic testing between families with MODY3 and a previously studied group at risk of hereditary non-polyposis colorectal cancer (HNPCC).Keywords
This publication has 32 references indexed in Scilit:
- Intrauterine Hyperglycemia Is Associated With an Earlier Diagnosis of Diabetes in HNF-1α Gene Mutation CarriersDiabetes Care, 2002
- Determinants of the Development of Diabetes (Maturity-Onset Diabetes of the Young-3) in Carriers of HNF-1α MutationsDiabetes Care, 2002
- Predictive genetic testing for hereditary non-polyposis colorectal cancer: Uptake and long-term satisfactionInternational Journal of Cancer, 2000
- Cancer risk associated with germline DNA mismatch repair gene mutationsHuman Molecular Genetics, 1997
- Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)Nature, 1996
- Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndromeInternational Journal of Cancer, 1995
- On attitudes and appreciation 6 months after predictive DNA testing for huntington disease in the Dutch programAmerican Journal of Medical Genetics, 1993
- Uptake of cystic fibrosis testing in primary care: supply push or demand pull?BMJ, 1993
- Predictive testing for Huntington disease in Canada: Adverse effects and unexpected results in those receiving a decreased riskAmerican Journal of Medical Genetics, 1992
- UPTAKE OF PRESYMPTOMATIC PREDICTIVE TESTING FOR HUNTINGTON'S DISEASEThe Lancet, 1989